Twist scientific conference series 2018

09:30 bis 16:00 Uhr
Kalendereintrag speichern
Crowne Plaza Berlin - Potzdamer Platz

Hallesche Straße 10,

10963 Berlin

This full day scientific symposium is packed with technical talks from renowned leaders in the fields of Next-Generation Sequencing (NGS) and Synthetic Biology. By attending this event, you will leave with a better understanding of how to improve your data quality output and overcome research obstacles when dealing with synthetic DNA and NGS Target Enrichment Solutions. You will also receive access to the networking lunch, which will acquaint you with other thought leaders in your industry.

 

SPEAKERS

 

  • Paul Carlson

    Helsinki University, Institute of Biotechnology

    M.Sc. PhD Student

  • Janus Guttesen

    Twist Bioscience

    Account Manager, Nordics & Northern Germany

  • Peter Kleinsmit

    Twist Bioscience

    NGS Specialist

  • Ewoud Ouwerkerk

    Twist Bioscience

    European District Business Manager

  • Marc Bruyinx, PhD

    Twist Bioscience

    Field Application Specialist Europe

  • Tina Han, PhD

    CeGaT

    R&D Team Lead

  • Michael Hannus, PhD

    SiTools

    CEO

  • David Öling, PhD

    AstraZeneca

    Postdoctoral Researcher

 

AGENDA

10:00
Welcome | Coffee & Refreshments

10:30
Global Challenges
Ewoud Ouwerkerk, Twist Bioscience

11:00
Introducion to Twist NGS Target Enrichment
Peter Kleinsmit, Twist Bioscience

11:15
Exome Seek: Looking Beyond Variant Calling from a More Precise Exome
Tina Han, PhD, CeGaT

11:45
Introduction to Twist Bioscience Genes
Janus Guttesen, Twist Bioscience

12:00
SiPools: Gene Synthesis Meets Precision RNAi
Michael Hannus, PhD, SiTools

12:30
Lunch | Coffee & Refreshments

13:30
Introduction to Twist Bioscience Oligo Pools
Marc Bruyninx, Twist Bioscience

13:45
New Proteome-Wide Screening Tools for Identifying Secretory Signals
Paul Carlson, Helsinki University, Institute of Biotechnology

14:15
Introduction to Twist Bioscience Variant Libraries
Marc Bruyinx, Twist Bioscience

14:30
Development of GPCR Biosensor for Synthetic Glucose Homeostasis Circuits
David Öling, PhD, AstraZeneca

15:00
Wrap Up | Q&A with the Technical Team

15:30
Drinks Reception